Gemcitabine, paclitaxel, and doxorubicin as first-line therapy for patients with advanced urothelial carcinoma and renal insufficiency: A phase II study.
Lance C. Pagliaro
No relevant relationships to disclose
Mark F. Munsell
No relevant relationships to disclose
Deborah Harris
No relevant relationships to disclose
Robert L. Carolla
No relevant relationships to disclose
Arlene O. Siefker-Radtke
No relevant relationships to disclose